ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

BIO.B Bio Rad Laboratories Inc

279.91
0.00 (0.00%)
May 02 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 5
Bid Price
Ask Price
News -
Day High 279.49

Low
268.80

52 Week Range

High
467.95

Day Low 279.49
Share Name Share Symbol Market Stock Type
Bio Rad Laboratories Inc BIO.B NYSE Common Stock
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 279.91 16:00:00
Open Price Low Price High Price Close Price Previous Close
279.49 279.49 279.49 279.91 279.91
Trades Shares Traded Average Volume 52 Week Range
5 5 - 268.80 - 467.95
Last Trade Type Quantity Price Currency
10:12:53 1 US$ 280.02 USD

Bio Rad Laboratories Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
7.98B 28.52M - 2.67B -637.32M -22.35 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Bio Rad Laboratories News

Date Time Source News Article
4/18/202408:00Business WireBio-Rad to Report First Quarter 2024 Financial Results on..
4/10/202415:15Business WireBio-Rad’s Chief Operating Officer Andrew Last to Retire
3/11/202408:59Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial..
2/29/202416:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/28/202417:38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/28/202417:24Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
2/27/202416:39Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
2/27/202416:35Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
2/21/202415:31Edgar (US Regulatory)Form 8-K - Current report
2/16/202415:31Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/15/202415:24Edgar (US Regulatory)Form 8-K - Current report
2/15/202415:15Business WireBio-Rad Reports Fourth-Quarter and Full-Year 2023 Financial..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No BIO.B Message Board. Create One! See More Posts on BIO.B Message Board See More Message Board Posts

Historical BIO.B Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week279.75279.91268.80279.91450.160.06%
1 Month331.38342.68268.80310.8995-51.47-15.53%
3 Months321.02357.67268.80333.30328-41.11-12.81%
6 Months273.00357.67268.80327.782096.912.53%
1 Year464.48467.95268.80338.03131-184.57-39.74%
3 Years631.85879.00268.80501.98110-351.94-55.70%
5 Years298.88879.00268.80461.56155-18.97-6.35%

Bio Rad Laboratories Description

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.

Your Recent History

Delayed Upgrade Clock